Tag: global open angle glaucoma oag market

Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

Open-Angle Glaucoma (OAG) Market Size And Revenue Forecast Through 2030

The open-angle glaucoma (oag) sector experienced a robust expansion lately and is projected to continue this trajectory, expanding from $6.53 billion in 2025 to $6.96 billion in 2026 with a compound annual growth rate (CAGR) of 6.5%. This historical growth surge was fueled by several factors, including restricted availability of face-to-face mental health support, an increasing incidence of anxiety and depression, heightened recognition of mental well-being’s significance, the escalating adoption of telemedicine services, and the early integration of online therapy solutions.

The market for open-angle glaucoma (oag) is poised for substantial expansion in the coming years, projected to reach $8.86 billion by 2030 with a compound annual growth rate of 6.2%. This anticipated growth is fueled by several key factors including an escalating demand for telehealth services, wider acceptance of digital counseling platforms, the growing incorporation of artificial intelligence in mental well-being solutions, the increasing prevalence of blended therapy approaches that merge one-on-one and group sessions, and a broader availability of online therapeutic options across both commercial and residential sectors. Significant developments expected during this forecast period involve a greater uptake of prostaglandin analog medications, increased utilization of micro-invasive surgical procedures for glaucoma, enhanced public awareness concerning early detection and screening protocols, a rise in remote ophthalmology consultations for managing oag, and ongoing advancements in the creation of combined pharmaceutical treatments.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20911&type=smp

Open-Angle Glaucoma (OAG) Market Development Factors: Which Trends Are Supporting Demand?

Increased consciousness regarding ocular ailments is anticipated to bolster the expansion of the open-angle glaucoma (OAG) market. Ocular conditions, which involve disorders affecting the physical integrity, performance, or visual capabilities of the eyes, span a spectrum from minor issues like dry eye to severe conditions such as glaucoma and macular degeneration. The increasing incidence of these conditions is linked to an aging global demographic, extended periods spent viewing digital screens, a rise in diabetes diagnoses, environmental contamination, and lifestyle choices detrimental to eye well-being. Open-angle glaucoma (OAG), a primary contributor to vision impairment, particularly in older individuals, highlights the imperative for regular eye examinations, prompt identification, and timely management to prevent permanent vision deterioration. Illustratively, in October 2023, the Royal National Institute of Blind People (RNIB) reported that UK outpatient appointments for eye care surpassed eight million during the 2021/22 period, establishing it as the foremost sought-after medical specialty. Furthermore, the existing population experiencing vision loss, already exceeding two million, is forecasted to double, reaching over four million by the year 2050. Consequently, heightened awareness surrounding eye diseases is fueling the expansion of the open-angle glaucoma (OAG) market.

Open-Angle Glaucoma (OAG) Market Segmentation Trends And Revenue Drivers

The open-angle glaucoma (oag) market covered in this report is segmented –

1) By Disease Type: Open Angle Glaucoma, Angle Closure Glaucoma, Other Disease Types

2) By Drug Class: Prostaglandin Analog, Beta Blockers, Adrenergic Agonist, Carbonic Anhydrase Inhibitors, Other Drug Classes

3) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users

4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

Subsegments:

1) By Open Angle Glaucoma (OAG): Primary Open-Angle Glaucoma (POAG), Secondary Open-Angle Glaucoma

2) By Angle Closure Glaucoma: Acute Angle-Closure Glaucoma, Chronic Angle-Closure Glaucoma

3) By Other Disease Types: Normal-Tension Glaucoma, Congenital Glaucoma, Secondary Glaucoma

Open-Angle Glaucoma (OAG) Market Transformation Trends: Which Innovations Are Driving Change?

Within the open-angle glaucoma (OAG) sector, leading businesses are actively focusing on creating novel approaches, exemplified by the advancement of minimally invasive glaucoma devices (MIGDs), which serve as sophisticated, gentler options for addressing primary open-angle glaucoma and diminishing the need for established interventions. A minimally invasive glaucoma device (MIGD) encompasses a spectrum of surgical implants and procedures engineered to decrease intraocular pressure in individuals with glaucoma, employing tiny incisions and minimal disturbance to the eye’s delicate tissues. As an illustration, in December 2023, the Belgian medtech firm iSTAR Medical introduced MINIject to the Dutch market. This innovative bio-integrating therapeutic employs a distinctive porous STAR material, specifically designed to improve fluid drainage and thereby lower intraocular pressure. Consequently, by lessening the reliance on conventional treatments, MINIject signifies a pivotal progression in glaucoma management, presenting a more secure and efficacious strategy for handling this primary contributor to irreversible vision loss.

Open-Angle Glaucoma (OAG) Market Industry Leaders: Which Organizations Are Driving Competition?

Major companies operating in the open-angle glaucoma (oag) market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Alcon Inc., Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Santen Pharmaceuticals, Théa Pharma, Glaukos Corporation, Quantel Medical, EyePoint Pharmaceuticals Inc., iSTAR Medical, Nicox Ophthalmics, Visus Therapeutics, Inotek Pharmaceuticals, Hoya Corporation, Boston Scientific, Ocular Therapeutix Inc., Carl Zeiss Meditec AG, Topcon Corporation, Nidek Co. Ltd., Heidelberg Engineering GmbH, New World Medical Inc.

Access The Complete Open-Angle Glaucoma (OAG) Market Report:

https://www.thebusinessresearchcompany.com/report/open-angle-glaucoma-oag-global-market-report

Open-Angle Glaucoma (OAG) Market Geographic Analysis: Where Is Demand Growing The Fastest?

North Americawas the largest region in the open-angle glaucoma (OAG) market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the open-angle glaucoma (oag) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Forecasted Rise In Market Size Of The Open-Angle Glaucoma (OAG) Market During The Forecast Period?

The open-angle glaucoma (oag) market size has demonstrated robust expansion in recent times. It is anticipated to expand from $6.53 billion in 2025 to $6.96 billion in 2026, reflecting a compound annual growth rate (CAGR) of 6.5%. The growth observed during the preceding period can be traced to challenges in accessing in-person mental health services, an increasing prevalence of anxiety and depression, heightened awareness regarding the significance of mental health, the rising adoption of early telemedicine platforms, and the initial integration of online counseling programs.

The market size for open-angle glaucoma (oag) is projected to experience significant growth in the upcoming years. It is expected to expand to $8.86 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.2%. This growth during the forecast period can be attributed to factors such as the increasing demand for accessible online therapy, the wider adoption of mobile and web-based counseling tools, the expanding integration of AI-powered mental wellness solutions, the growing utilization of hybrid therapy models that combine individual and group sessions, and the increased availability of online therapy offerings in both commercial and residential sectors. Prominent trends for this period include the rising adoption of prostaglandin analog drugs, an increase in the use of minimally invasive glaucoma surgeries, heightened awareness regarding early diagnosis and screening, an uptick in teleophthalmology consultations for oag management, and the accelerated development of combination drug therapies.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20911&type=smp

What Core Drivers Are Transforming The Open-Angle Glaucoma (OAG) Market?

Increasing recognition of eye conditions is anticipated to fuel the expansion of the open-angle glaucoma (OAG) market in the future. Eye conditions encompass medical issues affecting the eyes’ structure, function, or sight, varying from minor problems like dry eye to severe ailments such as glaucoma and macular degeneration. The incidence of these conditions is increasing, attributed to factors such as an aging demographic, extended periods of screen use, a rise in diabetes diagnoses, environmental pollutants, and lifestyle choices detrimental to ocular health. Open-angle glaucoma (OAG), a primary contributor to blindness, particularly in older individuals, highlights the vital importance of regular eye examinations, prompt diagnosis, and active treatment to prevent permanent loss of vision. As an illustration, data from October 2023, supplied by the Royal National Institute of Blind People (RNIB), a UK sight loss charity, indicated that eye care outpatient appointments in the UK surpassed eight million in 2021/22, positioning it as the most sought-after medical specialty. Furthermore, the population experiencing sight loss, currently exceeding two million, is forecast to double to more than four million by 2050. Consequently, heightened awareness regarding eye conditions is propelling expansion within the open-angle glaucoma (OAG) market.

How Is The Open-Angle Glaucoma (OAG) Market Examined Through Segment Analysis?

The open-angle glaucoma (oag) market covered in this report is segmented –

1) By Disease Type: Open Angle Glaucoma, Angle Closure Glaucoma, Other Disease Types

2) By Drug Class: Prostaglandin Analog, Beta Blockers, Adrenergic Agonist, Carbonic Anhydrase Inhibitors, Other Drug Classes

3) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users

4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

Subsegments:

1) By Open Angle Glaucoma (OAG): Primary Open-Angle Glaucoma (POAG), Secondary Open-Angle Glaucoma

2) By Angle Closure Glaucoma: Acute Angle-Closure Glaucoma, Chronic Angle-Closure Glaucoma

3) By Other Disease Types: Normal-Tension Glaucoma, Congenital Glaucoma, Secondary Glaucoma

Which Trends Are Influencing The Expansion Of The Open-Angle Glaucoma (OAG) Market?

Leading companies in the onychomycosis treatment market are prioritizing the development of new products, such as MOB-015, and securing their approval from federal agencies to achieve a competitive advantage. An illustration of this is Moberg Pharma AB, a pharmaceutical company based in Sweden, which obtained approval for MOB-015 in the European Union in June 2023. This approval is for the treatment of mild to moderate fungal infections of the nails in adults. This European Union endorsement signifies the first global marketing authorization for this innovative onychomycosis medication. The approval of MOB-015 was substantiated by two Phase 3 trials, which demonstrated an enhanced mycological cure rate of 76% versus up to 42% for comparators, alongside a considerably higher total cure rate than the vehicle, all without any serious adverse effects. The topical terbinafine formulation MOB-015 enables effective concentrations of terbinafine to reach the nail and nail bed without the systemic exposure risks associated with oral terbinafine treatment.

Which Organizations Are Operating Within The Open-Angle Glaucoma (OAG) Market?

Major companies operating in the open-angle glaucoma (oag) market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Alcon Inc., Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Santen Pharmaceuticals, Théa Pharma, Glaukos Corporation, Quantel Medical, EyePoint Pharmaceuticals Inc., iSTAR Medical, Nicox Ophthalmics, Visus Therapeutics, Inotek Pharmaceuticals, Hoya Corporation, Boston Scientific, Ocular Therapeutix Inc., Carl Zeiss Meditec AG, Topcon Corporation, Nidek Co. Ltd., Heidelberg Engineering GmbH, New World Medical Inc.

Access The Complete Open-Angle Glaucoma (OAG) Market Report:

https://www.thebusinessresearchcompany.com/report/open-angle-glaucoma-oag-global-market-report

Which Region Contributes The Most To The Open-Angle Glaucoma (OAG) Market?

North America was the largest region in the open-angle glaucoma (OAG) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the open-angle glaucoma (oag) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Open-Angle Glaucoma (OAG) Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=20911&type=smp

Browse Through More Reports Similar to the Global Open-Angle Glaucoma (OAG) Market 2026, By The Business Research Company

Onychomycosis Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/onychomycosis-global-market-report

Yeast Infection Treatment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/yeast-infection-treatment-global-market-report

Aspergillosis Treatment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/aspergillosis-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Level Of Market Value Growth Is Predicted For The Open-Angle Glaucoma (OAG) Market From 2026 To 2030?

The open-angle glaucoma (oag) market size has demonstrated robust expansion recently. It is forecast to rise from $6.53 billion in 2025 to $6.96 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.5%. Historically, this growth can be attributed to several factors, including limited access to in-person mental health services, the increasing prevalence of anxiety and depression, heightened awareness of mental health importance, the expanding use of early telemedicine platforms, and the initial adoption of online counseling programs.

The market for open-angle glaucoma (oag) is anticipated to experience substantial growth over the coming years. Projections indicate it will reach $8.86 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.2%. This expansion during the forecast period is fueled by several factors, including an escalating demand for easily accessible online therapy, a rise in the uptake of mobile and web-based counseling tools, the increasing integration of AI-powered mental wellness solutions, a growing preference for hybrid therapy models that combine individual and group sessions, and the broader availability of online therapy services across both commercial and residential sectors. Key trends anticipated during this period encompass the growing acceptance of prostaglandin analog drugs, a greater reliance on minimally invasive glaucoma surgeries, enhanced awareness leading to earlier diagnosis and screening, an uptick in teleophthalmology consultations for managing OAG, and continued advancements in combination drug therapies.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20911&type=smp

What Factors Are Contributing To The Growth Of The Open-Angle Glaucoma (OAG) Market?

Increased understanding of eye diseases is projected to drive the expansion of the open-angle glaucoma (OAG) market in the future. Eye diseases encompass various medical conditions affecting the structure, function, or sight of the eyes, ranging from minor issues like dry eye to severe conditions such as glaucoma and macular degeneration. Their occurrence is rising due to an aging global population, extended periods of screen usage, an increase in diabetes cases, environmental pollutants, and lifestyle choices that negatively impact eye health. Open-angle glaucoma (OAG), a primary cause of blindness, particularly in older individuals, highlights the vital necessity for regular eye check-ups, prompt diagnosis, and active treatment to prevent permanent vision impairment. For instance, in October 2023, according to the Royal National Institute of Blind People (RNIB), a UK-based sight loss charity, eye care outpatient appointments in the UK surpassed eight million in 2021/22, making it the most sought-after medical specialty. Additionally, the population with sight loss, which currently exceeds two million, is expected to double to more than four million by 2050. Consequently, heightened awareness of eye illnesses is fueling growth in the open-angle glaucoma (OAG) market.

Which Segment Classifications Are Used In The Open-Angle Glaucoma (OAG) Market Segment Analysis?

The open-angle glaucoma (oag) market covered in this report is segmented –

1) By Disease Type: Open Angle Glaucoma, Angle Closure Glaucoma, Other Disease Types

2) By Drug Class: Prostaglandin Analog, Beta Blockers, Adrenergic Agonist, Carbonic Anhydrase Inhibitors, Other Drug Classes

3) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users

4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

Subsegments:

1) By Open Angle Glaucoma (OAG): Primary Open-Angle Glaucoma (POAG), Secondary Open-Angle Glaucoma

2) By Angle Closure Glaucoma: Acute Angle-Closure Glaucoma, Chronic Angle-Closure Glaucoma

3) By Other Disease Types: Normal-Tension Glaucoma, Congenital Glaucoma, Secondary Glaucoma

What Trends Are Shaping The Future Of The Open-Angle Glaucoma (OAG) Market?

Major companies within the open-angle glaucoma (OAG) market are prioritizing the development of innovative solutions, such as minimally invasive glaucoma devices (MIGDs), to provide advanced and less intrusive alternatives for managing primary open-angle glaucoma, thereby reducing reliance on traditional treatments. A minimally invasive glaucoma device (MIGD) refers to a variety of surgical implants and techniques designed to lower intraocular pressure in glaucoma patients through small incisions and minimal disruption of ocular tissues. For instance, in December 2023, iSTAR Medical, a Belgium-based medtech company, launched MINIject in the Netherlands. This bio-integrating treatment for primary open-angle glaucoma utilizes a unique porous STAR material to enhance fluid outflow and reduce IOP. By decreasing dependency on conventional therapies, MINIject represents a significant breakthrough in glaucoma care, offering a safer and more effective management option for this leading cause of permanent blindness.

Which Firms Are Contributing To The Open-Angle Glaucoma (OAG) Market Ecosystem?

Major companies operating in the open-angle glaucoma (oag) market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Alcon Inc., Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Santen Pharmaceuticals, Théa Pharma, Glaukos Corporation, Quantel Medical, EyePoint Pharmaceuticals Inc., iSTAR Medical, Nicox Ophthalmics, Visus Therapeutics, Inotek Pharmaceuticals, Hoya Corporation, Boston Scientific, Ocular Therapeutix Inc., Carl Zeiss Meditec AG, Topcon Corporation, Nidek Co. Ltd., Heidelberg Engineering GmbH, New World Medical Inc.

Get The Full Open-Angle Glaucoma (OAG) Market Report:

https://www.thebusinessresearchcompany.com/report/open-angle-glaucoma-oag-global-market-report

Which Region Leads The Open-Angle Glaucoma (OAG) Market In Overall Market Size?

North America was the largest region in the open-angle glaucoma (OAG) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the open-angle glaucoma (oag) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Open-Angle Glaucoma (OAG) Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/open-angle-glaucoma-oag-global-market-report

Browse Through More Reports Similar to the Global Open-Angle Glaucoma (OAG) Market 2026, By The Business Research Company

Onychomycosis Market Report 2026

https://www.thebusinessresearchcompany.com/report/onychomycosis-global-market-report

Yeast Infection Treatment Market Report

https://www.thebusinessresearchcompany.com/report/yeast-infection-treatment-global-market-report

Aspergillosis Treatment Market Report

https://www.thebusinessresearchcompany.com/report/aspergillosis-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Expected Market Size Of The Open-Angle Glaucoma (OAG) Market From 2026 To 2030?

The open-angle glaucoma (oag) market has demonstrated robust growth over recent years. Its size is projected to expand from $6.53 billion in 2025 to $6.96 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.5%. Historically, this expansion was driven by factors such as limited access to in-person mental health services, a rising prevalence of anxiety and depression, increased awareness regarding the importance of mental health, the growing utilization of early telemedicine platforms, and the early adoption of online counseling programs.

The open-angle glaucoma (OAG) market size is anticipated to experience substantial growth in the coming years. It is projected to expand to $8.86 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.2%. This growth during the forecast period can be attributed to an escalating demand for accessible online therapy, the increasing adoption of mobile and web-based counseling tools, the growing integration of AI-powered mental wellness solutions, a rising utilization of hybrid therapy models combining individual and group sessions, and the expansion of online therapy offerings in commercial and residential segments. Significant trends within this period include the rising adoption of prostaglandin analog drugs, the increasing use of minimally invasive glaucoma surgeries, growing awareness about early diagnosis and screening, a rise in teleophthalmology consultations for OAG management, and the increasing development of combination drug therapies.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20911&type=smp

What Major Drivers Are Influencing Demand In The Open-Angle Glaucoma (OAG) Market?

The rising understanding of eye-related ailments is set to advance the open-angle glaucoma (OAG) market in the future. Eye illnesses encompass various medical conditions that affect the structure, operation, or visual capacity of the eyes, varying from minor issues like dry eye to serious disorders such as glaucoma and macular degeneration. Their occurrence is escalating due to factors such as an aging global populace, prolonged exposure to screens, a rise in diabetes cases, environmental pollutants, and lifestyle choices that compromise eye health. Open-angle glaucoma (OAG), a primary contributor to blindness, particularly among older individuals, underscores the vital importance of consistent eye examinations, prompt diagnosis, and proactive therapeutic interventions to avert permanent vision impairment. A notable example, provided in October 2023 by the Royal National Institute of Blind People (RNIB), a UK-based charity focused on sight loss, revealed that eye care outpatient appointments in the UK surpassed eight million in 2021/22, establishing it as the most sought-after medical specialty. Furthermore, the population affected by sight loss, currently exceeding two million, is projected to double to over four million by 2050. Consequently, the increasing awareness of eye illnesses is a key catalyst for growth within the open-angle glaucoma (OAG) market.

Which Segments Are Included In The Analysis Of The Open-Angle Glaucoma (OAG) Market?

The open-angle glaucoma (oag) market covered in this report is segmented –

1) By Disease Type: Open Angle Glaucoma, Angle Closure Glaucoma, Other Disease Types

2) By Drug Class: Prostaglandin Analog, Beta Blockers, Adrenergic Agonist, Carbonic Anhydrase Inhibitors, Other Drug Classes

3) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users

4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

Subsegments:

1) By Open Angle Glaucoma (OAG): Primary Open-Angle Glaucoma (POAG), Secondary Open-Angle Glaucoma

2) By Angle Closure Glaucoma: Acute Angle-Closure Glaucoma, Chronic Angle-Closure Glaucoma

3) By Other Disease Types: Normal-Tension Glaucoma, Congenital Glaucoma, Secondary Glaucoma

What Key Trends Are Influencing The Development Of The Open-Angle Glaucoma (OAG) Market?

Leading companies active in the open-angle glaucoma (OAG) market are prioritizing the creation of innovative solutions, such as minimally invasive glaucoma devices (MIGDs), to deliver advanced and less intrusive options for managing primary open-angle glaucoma, reducing reliance on traditional treatments. A minimally invasive glaucoma device (MIGD) describes a variety of surgical implants and techniques developed to decrease intraocular pressure in glaucoma patients using small incisions and minimal disturbance to ocular tissues. For example, in December 2023, iSTAR Medical, a medtech company from Belgium, introduced MINIject in the Netherlands. This bio-integrating therapy for primary open-angle glaucoma leverages a distinctive porous STAR material to improve fluid outflow and reduce IOP. By lessening dependence on conventional therapies, MINIject signifies a considerable advancement in glaucoma care, providing a safer and more efficient management choice for this principal cause of permanent blindness.

Which Key Industry Participants Are Active In The Open-Angle Glaucoma (OAG) Market?

Major companies operating in the open-angle glaucoma (oag) market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Alcon Inc., Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Santen Pharmaceuticals, Théa Pharma, Glaukos Corporation, Quantel Medical, EyePoint Pharmaceuticals Inc., iSTAR Medical, Nicox Ophthalmics, Visus Therapeutics, Inotek Pharmaceuticals, Hoya Corporation, Boston Scientific, Ocular Therapeutix Inc., Carl Zeiss Meditec AG, Topcon Corporation, Nidek Co. Ltd., Heidelberg Engineering GmbH, New World Medical Inc.

Read the full open-angle glaucoma (oag) market report here:

https://www.thebusinessresearchcompany.com/report/open-angle-glaucoma-oag-global-market-report

Which Region Shows The Strongest Potential For Future Growth In The Open-Angle Glaucoma (OAG) Market?

North America was the largest region in the open-angle glaucoma (OAG) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the open-angle glaucoma (oag) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Open-Angle Glaucoma (OAG) Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20911&type=smp

Browse Through More Reports Similar to the Global Open-Angle Glaucoma (OAG) Market 2026, By The Business Research Company

Onychomycosis Global Market Report

https://www.thebusinessresearchcompany.com/report/onychomycosis-global-market-report

Yeast Infection Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/yeast-infection-treatment-global-market-report

Aspergillosis Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/aspergillosis-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Expected Market Size Of The Open-Angle Glaucoma (OAG) Market From 2026 To 2030?

The open-angle glaucoma (oag) market has demonstrated robust growth over recent years. Its size is projected to expand from $6.53 billion in 2025 to $6.96 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.5%. Historically, this expansion was driven by factors such as limited access to in-person mental health services, a rising prevalence of anxiety and depression, increased awareness regarding the importance of mental health, the growing utilization of early telemedicine platforms, and the early adoption of online counseling programs.

The open-angle glaucoma (OAG) market size is anticipated to experience substantial growth in the coming years. It is projected to expand to $8.86 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.2%. This growth during the forecast period can be attributed to an escalating demand for accessible online therapy, the increasing adoption of mobile and web-based counseling tools, the growing integration of AI-powered mental wellness solutions, a rising utilization of hybrid therapy models combining individual and group sessions, and the expansion of online therapy offerings in commercial and residential segments. Significant trends within this period include the rising adoption of prostaglandin analog drugs, the increasing use of minimally invasive glaucoma surgeries, growing awareness about early diagnosis and screening, a rise in teleophthalmology consultations for OAG management, and the increasing development of combination drug therapies.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20911&type=smp

What Major Drivers Are Influencing Demand In The Open-Angle Glaucoma (OAG) Market?

The rising understanding of eye-related ailments is set to advance the open-angle glaucoma (OAG) market in the future. Eye illnesses encompass various medical conditions that affect the structure, operation, or visual capacity of the eyes, varying from minor issues like dry eye to serious disorders such as glaucoma and macular degeneration. Their occurrence is escalating due to factors such as an aging global populace, prolonged exposure to screens, a rise in diabetes cases, environmental pollutants, and lifestyle choices that compromise eye health. Open-angle glaucoma (OAG), a primary contributor to blindness, particularly among older individuals, underscores the vital importance of consistent eye examinations, prompt diagnosis, and proactive therapeutic interventions to avert permanent vision impairment. A notable example, provided in October 2023 by the Royal National Institute of Blind People (RNIB), a UK-based charity focused on sight loss, revealed that eye care outpatient appointments in the UK surpassed eight million in 2021/22, establishing it as the most sought-after medical specialty. Furthermore, the population affected by sight loss, currently exceeding two million, is projected to double to over four million by 2050. Consequently, the increasing awareness of eye illnesses is a key catalyst for growth within the open-angle glaucoma (OAG) market.

Which Segments Are Included In The Analysis Of The Open-Angle Glaucoma (OAG) Market?

The open-angle glaucoma (oag) market covered in this report is segmented –

1) By Disease Type: Open Angle Glaucoma, Angle Closure Glaucoma, Other Disease Types

2) By Drug Class: Prostaglandin Analog, Beta Blockers, Adrenergic Agonist, Carbonic Anhydrase Inhibitors, Other Drug Classes

3) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users

4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

Subsegments:

1) By Open Angle Glaucoma (OAG): Primary Open-Angle Glaucoma (POAG), Secondary Open-Angle Glaucoma

2) By Angle Closure Glaucoma: Acute Angle-Closure Glaucoma, Chronic Angle-Closure Glaucoma

3) By Other Disease Types: Normal-Tension Glaucoma, Congenital Glaucoma, Secondary Glaucoma

What Key Trends Are Influencing The Development Of The Open-Angle Glaucoma (OAG) Market?

Leading companies active in the open-angle glaucoma (OAG) market are prioritizing the creation of innovative solutions, such as minimally invasive glaucoma devices (MIGDs), to deliver advanced and less intrusive options for managing primary open-angle glaucoma, reducing reliance on traditional treatments. A minimally invasive glaucoma device (MIGD) describes a variety of surgical implants and techniques developed to decrease intraocular pressure in glaucoma patients using small incisions and minimal disturbance to ocular tissues. For example, in December 2023, iSTAR Medical, a medtech company from Belgium, introduced MINIject in the Netherlands. This bio-integrating therapy for primary open-angle glaucoma leverages a distinctive porous STAR material to improve fluid outflow and reduce IOP. By lessening dependence on conventional therapies, MINIject signifies a considerable advancement in glaucoma care, providing a safer and more efficient management choice for this principal cause of permanent blindness.

Which Key Industry Participants Are Active In The Open-Angle Glaucoma (OAG) Market?

Major companies operating in the open-angle glaucoma (oag) market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Alcon Inc., Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Santen Pharmaceuticals, Théa Pharma, Glaukos Corporation, Quantel Medical, EyePoint Pharmaceuticals Inc., iSTAR Medical, Nicox Ophthalmics, Visus Therapeutics, Inotek Pharmaceuticals, Hoya Corporation, Boston Scientific, Ocular Therapeutix Inc., Carl Zeiss Meditec AG, Topcon Corporation, Nidek Co. Ltd., Heidelberg Engineering GmbH, New World Medical Inc.

Read the full open-angle glaucoma (oag) market report here:

https://www.thebusinessresearchcompany.com/report/open-angle-glaucoma-oag-global-market-report

Which Region Shows The Strongest Potential For Future Growth In The Open-Angle Glaucoma (OAG) Market?

North America was the largest region in the open-angle glaucoma (OAG) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the open-angle glaucoma (oag) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Open-Angle Glaucoma (OAG) Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20911&type=smp

Browse Through More Reports Similar to the Global Open-Angle Glaucoma (OAG) Market 2026, By The Business Research Company

Onychomycosis Global Market Report

https://www.thebusinessresearchcompany.com/report/onychomycosis-global-market-report

Yeast Infection Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/yeast-infection-treatment-global-market-report

Aspergillosis Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/aspergillosis-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Expected Market Size Of The Open-Angle Glaucoma (OAG) Market From 2026 To 2030?

The open-angle glaucoma (oag) market has demonstrated robust growth over recent years. Its size is projected to expand from $6.53 billion in 2025 to $6.96 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.5%. Historically, this expansion was driven by factors such as limited access to in-person mental health services, a rising prevalence of anxiety and depression, increased awareness regarding the importance of mental health, the growing utilization of early telemedicine platforms, and the early adoption of online counseling programs.

The open-angle glaucoma (OAG) market size is anticipated to experience substantial growth in the coming years. It is projected to expand to $8.86 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.2%. This growth during the forecast period can be attributed to an escalating demand for accessible online therapy, the increasing adoption of mobile and web-based counseling tools, the growing integration of AI-powered mental wellness solutions, a rising utilization of hybrid therapy models combining individual and group sessions, and the expansion of online therapy offerings in commercial and residential segments. Significant trends within this period include the rising adoption of prostaglandin analog drugs, the increasing use of minimally invasive glaucoma surgeries, growing awareness about early diagnosis and screening, a rise in teleophthalmology consultations for OAG management, and the increasing development of combination drug therapies.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20911&type=smp

What Major Drivers Are Influencing Demand In The Open-Angle Glaucoma (OAG) Market?

The rising understanding of eye-related ailments is set to advance the open-angle glaucoma (OAG) market in the future. Eye illnesses encompass various medical conditions that affect the structure, operation, or visual capacity of the eyes, varying from minor issues like dry eye to serious disorders such as glaucoma and macular degeneration. Their occurrence is escalating due to factors such as an aging global populace, prolonged exposure to screens, a rise in diabetes cases, environmental pollutants, and lifestyle choices that compromise eye health. Open-angle glaucoma (OAG), a primary contributor to blindness, particularly among older individuals, underscores the vital importance of consistent eye examinations, prompt diagnosis, and proactive therapeutic interventions to avert permanent vision impairment. A notable example, provided in October 2023 by the Royal National Institute of Blind People (RNIB), a UK-based charity focused on sight loss, revealed that eye care outpatient appointments in the UK surpassed eight million in 2021/22, establishing it as the most sought-after medical specialty. Furthermore, the population affected by sight loss, currently exceeding two million, is projected to double to over four million by 2050. Consequently, the increasing awareness of eye illnesses is a key catalyst for growth within the open-angle glaucoma (OAG) market.

Which Segments Are Included In The Analysis Of The Open-Angle Glaucoma (OAG) Market?

The open-angle glaucoma (oag) market covered in this report is segmented –

1) By Disease Type: Open Angle Glaucoma, Angle Closure Glaucoma, Other Disease Types

2) By Drug Class: Prostaglandin Analog, Beta Blockers, Adrenergic Agonist, Carbonic Anhydrase Inhibitors, Other Drug Classes

3) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users

4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

Subsegments:

1) By Open Angle Glaucoma (OAG): Primary Open-Angle Glaucoma (POAG), Secondary Open-Angle Glaucoma

2) By Angle Closure Glaucoma: Acute Angle-Closure Glaucoma, Chronic Angle-Closure Glaucoma

3) By Other Disease Types: Normal-Tension Glaucoma, Congenital Glaucoma, Secondary Glaucoma

What Key Trends Are Influencing The Development Of The Open-Angle Glaucoma (OAG) Market?

Leading companies active in the open-angle glaucoma (OAG) market are prioritizing the creation of innovative solutions, such as minimally invasive glaucoma devices (MIGDs), to deliver advanced and less intrusive options for managing primary open-angle glaucoma, reducing reliance on traditional treatments. A minimally invasive glaucoma device (MIGD) describes a variety of surgical implants and techniques developed to decrease intraocular pressure in glaucoma patients using small incisions and minimal disturbance to ocular tissues. For example, in December 2023, iSTAR Medical, a medtech company from Belgium, introduced MINIject in the Netherlands. This bio-integrating therapy for primary open-angle glaucoma leverages a distinctive porous STAR material to improve fluid outflow and reduce IOP. By lessening dependence on conventional therapies, MINIject signifies a considerable advancement in glaucoma care, providing a safer and more efficient management choice for this principal cause of permanent blindness.

Which Key Industry Participants Are Active In The Open-Angle Glaucoma (OAG) Market?

Major companies operating in the open-angle glaucoma (oag) market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Alcon Inc., Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Santen Pharmaceuticals, Théa Pharma, Glaukos Corporation, Quantel Medical, EyePoint Pharmaceuticals Inc., iSTAR Medical, Nicox Ophthalmics, Visus Therapeutics, Inotek Pharmaceuticals, Hoya Corporation, Boston Scientific, Ocular Therapeutix Inc., Carl Zeiss Meditec AG, Topcon Corporation, Nidek Co. Ltd., Heidelberg Engineering GmbH, New World Medical Inc.

Read the full open-angle glaucoma (oag) market report here:

https://www.thebusinessresearchcompany.com/report/open-angle-glaucoma-oag-global-market-report

Which Region Shows The Strongest Potential For Future Growth In The Open-Angle Glaucoma (OAG) Market?

North America was the largest region in the open-angle glaucoma (OAG) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the open-angle glaucoma (oag) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Open-Angle Glaucoma (OAG) Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20911&type=smp

Browse Through More Reports Similar to the Global Open-Angle Glaucoma (OAG) Market 2026, By The Business Research Company

Onychomycosis Global Market Report

https://www.thebusinessresearchcompany.com/report/onychomycosis-global-market-report

Yeast Infection Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/yeast-infection-treatment-global-market-report

Aspergillosis Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/aspergillosis-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the open-angle glaucoma (oag) market from 2026–2035 with trusted insights from The Business Research Company

What is the estimated market size of the Open-Angle Glaucoma (OAG) Market by the end of 2030?

The open-angle glaucoma (oag) market has demonstrated strong growth in recent years. This market is anticipated to expand from $6.53 billion in 2025 to $6.96 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.5%. In the past, this growth was primarily fueled by limited access to in-person mental health services, an increasing prevalence of anxiety and depression, greater awareness regarding the importance of mental health, the rising adoption of early telemedicine platforms, and the early implementation of online counseling programs.

The open-angle glaucoma (oag) market is projected to experience substantial growth in the coming years, with its size expected to reach $8.86 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.2%. This anticipated growth during the forecast period can be attributed to factors such as an increasing demand for accessible online therapy, the rising adoption of mobile and web-based counseling tools, the growing integration of AI-powered mental wellness solutions, an increasing utilization of hybrid therapy models that combine individual and group sessions, and the expansion of online therapy offerings in both commercial and residential sectors. Furthermore, key trends anticipated for the forecast period include a rising adoption of prostaglandin analog drugs, an increasing use of minimally invasive glaucoma surgeries, enhanced awareness regarding early diagnosis and screening, an uptick in teleophthalmology consultations for oag management, and the continued development of combination drug therapies.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20911&type=smp

What Drivers Are Shaping Future Opportunities In The Open-Angle Glaucoma (OAG) Market?

The open-angle glaucoma (OAG) market is expected to expand going forward due to increasing public understanding of eye illnesses. These conditions encompass medical issues impacting the eye’s structure, function, or vision, ranging from minor problems like dry eye to severe ailments such as glaucoma and macular degeneration. Their prevalence is rising, influenced by an aging global population, increased screen time, a growing number of diabetes cases, environmental pollution, and lifestyle choices that negatively affect eye health. Open-angle glaucoma (OAG) stands as a leading cause of blindness, particularly among older adults, emphasizing the critical importance of regular eye exams, early detection, and proactive treatment to prevent irreversible vision loss. For instance, in October 2023, information from the Royal National Institute of Blind People (RNIB), a UK-based sight loss charity, indicated that eye care outpatient appointments in the UK surpassed eight million in 2021/22, making it the most demanded specialty. Moreover, the number of individuals experiencing sight loss, currently exceeding two million, is anticipated to double to over four million by 2050. Thus, the escalating awareness concerning eye illnesses is fueling growth in the open-angle glaucoma (OAG) market.

Which Segments Are Gaining Traction In The Open-Angle Glaucoma (OAG) Market?

The open-angle glaucoma (oag) market covered in this report is segmented –

1) By Disease Type: Open Angle Glaucoma, Angle Closure Glaucoma, Other Disease Types

2) By Drug Class: Prostaglandin Analog, Beta Blockers, Adrenergic Agonist, Carbonic Anhydrase Inhibitors, Other Drug Classes

3) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users

4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

Subsegments:

1) By Open Angle Glaucoma (OAG): Primary Open-Angle Glaucoma (POAG), Secondary Open-Angle Glaucoma

2) By Angle Closure Glaucoma: Acute Angle-Closure Glaucoma, Chronic Angle-Closure Glaucoma

3) By Other Disease Types: Normal-Tension Glaucoma, Congenital Glaucoma, Secondary Glaucoma

Which Trends Are Guiding The Evolution Of The Open-Angle Glaucoma (OAG) Market?

Major companies active in the open-angle glaucoma (OAG) market are prioritizing the development of innovative solutions, such as minimally invasive glaucoma devices (MIGDs), to provide advanced and less invasive alternatives for managing primary open-angle glaucoma while reducing reliance on traditional treatments. A minimally invasive glaucoma device (MIGD) refers to a range of surgical implants and techniques designed to lower intraocular pressure in glaucoma patients through small incisions and minimal disruption of ocular tissues. For instance, in December 2023, iSTAR Medical, a Belgium-based medtech company, introduced MINIject in the Netherlands. This bio-integrating treatment for primary open-angle glaucoma utilizes a unique porous STAR material to enhance fluid outflow and reduce IOP. By decreasing dependency on conventional therapies, MINIject represents a significant breakthrough in glaucoma care, offering a safer and more effective management option for this leading cause of permanent blindness.

Who Are The Prominent Global Companies Shaping The Open-Angle Glaucoma (OAG) Market Landscape?

Major companies operating in the open-angle glaucoma (oag) market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Alcon Inc., Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Santen Pharmaceuticals, Théa Pharma, Glaukos Corporation, Quantel Medical, EyePoint Pharmaceuticals Inc., iSTAR Medical, Nicox Ophthalmics, Visus Therapeutics, Inotek Pharmaceuticals, Hoya Corporation, Boston Scientific, Ocular Therapeutix Inc., Carl Zeiss Meditec AG, Topcon Corporation, Nidek Co. Ltd., Heidelberg Engineering GmbH, New World Medical Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/open-angle-glaucoma-oag-global-market-report

Which Region Is Projected To Lead The Open-Angle Glaucoma (OAG) Market During The Forecast Period?

North America was the largest region in the open-angle glaucoma (OAG) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the open-angle glaucoma (oag) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Open-Angle Glaucoma (OAG) Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20911&type=smp

Browse Through More Reports Similar to the Global Open-Angle Glaucoma (OAG) Market 2026, By The Business Research Company

Ocular Implants Market Report 2026

https://www.thebusinessresearchcompany.com/report/ocular-implants-global-market-report

Minimally Invasive Glaucoma Surgery Migs Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/minimally-invasive-glaucoma-surgery-migs-devices-global-market-report

Ocular Hypertension Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/ocular-hypertension-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model